Blastic plasmacytoid dendritic cell neoplasm.

Area of Science:

• Hematology
• Dermatology
• Oncology

Background:

• Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive hematologic malignancy.
• It has a poor prognosis with a median survival of approximately one year.
• Early detection is crucial for improving patient outcomes.

Observation:

• A 65-year-old man presented with a rapidly growing forehead nodule.
• Initial treatment for presumed infection and inflammation was ineffective.
• Subsequent development of ecchymosis, edema, and erythematous patches prompted further investigation.

Findings:

• Biopsy and immunohistochemical analysis confirmed BPDCN.
• The patient achieved sustained complete remission 18 months post-hematopoietic stem cell transplantation.
• Cutaneous presentations of BPDCN can mimic benign dermatological conditions, such as bruises.

Implications:

• High clinical suspicion and prompt biopsy are essential for diagnosing BPDCN, especially with atypical cutaneous manifestations.
• Hematopoietic stem cell transplantation offers a potential treatment option for achieving remission.
• Increased awareness among healthcare providers can lead to earlier diagnosis and intervention for this rare neoplasm.